Uncategorized
RESPOND study: Iluvien effective at 6 months in DME patients
Iluvien was effective and well tolerated in reducing retinal thickness and improving visual acuity in patients with chronic diabetic macular edema, Alimera Sciences announced in a press release.Alimera Sciences Limited, the company’s European subsidiary, announced the interim 6-month results of the RESPOND study at the Euretina congress in Nice, France.